tiprankstipranks
Advertisement
Advertisement

OTLK Stock Latest News

Darden, Outlook, Boyd, Garmin, Scotts: Insider Trade Shock
Weekend UpdatesDarden, Outlook, Boyd, Garmin, Scotts: Insider Trade Shock
2d ago
BYD
DRI
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
PremiumWeekend Updates
OTLK, HBAN, CORT, CAPR, GOSS Trending With Analysts
2d ago
CAPR
CORT
Outlook Therapeutics price target raised to $1.60 from 50c at H.C. Wainwright
PremiumThe Fly
Outlook Therapeutics price target raised to $1.60 from 50c at H.C. Wainwright
7d ago
OTLK
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe Fly
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
7d ago
OTLK
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
PremiumThe Fly
Outlook Therapeutics upgraded to Buy from Neutral at BTIG
7d ago
OTLK
Outlook Therapeutics Gains FDA Approval for LYTENAVA Launch
PremiumCompany AnnouncementsOutlook Therapeutics Gains FDA Approval for LYTENAVA Launch
10d ago
8K
OTLK
Outlook Therapeutics Inc trading resumes
Premium
The Fly
Outlook Therapeutics Inc trading resumes
10d ago
OTLK
Outlook Therapeutics announces FDA approval of Lytenava for wet AMD
Premium
The Fly
Outlook Therapeutics announces FDA approval of Lytenava for wet AMD
10d ago
OTLK
Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment
PremiumThe Fly
Outlook jumps 24% to $1.64 after FDA approves wet AMD treatment
10d ago
OTLK
Outlook Therapeutics Inc trading halted, news pending
PremiumThe Fly
Outlook Therapeutics Inc trading halted, news pending
10d ago
OTLK
Outlook Therapeutics Grants Incentive Awards Tied to FDA Approval
PremiumCompany Announcements
Outlook Therapeutics Grants Incentive Awards Tied to FDA Approval
10d ago
8K
OTLK
Outlook Therapeutics registers to sell 17.26M shares of common stock for holders
PremiumThe Fly
Outlook Therapeutics registers to sell 17.26M shares of common stock for holders
17d ago
OTLK
Outlook Therapeutics Shareholders Approve Major Capital Changes
PremiumCompany AnnouncementsOutlook Therapeutics Shareholders Approve Major Capital Changes
17d ago
8K
OTLK
Outlook Therapeutics Regains Nasdaq Minimum Bid Compliance
Premium
Company Announcements
Outlook Therapeutics Regains Nasdaq Minimum Bid Compliance
1M ago
8K
OTLK
Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA
Premium
Company Announcements
Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA
2M ago
8K
OTLK
Outlook Therapeutics resubmits ONS-5010 biologics license application to FDA
PremiumThe Fly
Outlook Therapeutics resubmits ONS-5010 biologics license application to FDA
2M ago
OTLK
Outlook Therapeutics Resubmits FDA Application for ONS-5010
PremiumCompany Announcements
Outlook Therapeutics Resubmits FDA Application for ONS-5010
2M ago
8K
OTLK
Outlook Therapeutics resubmits biologics license application to FDA
PremiumThe Fly
Outlook Therapeutics resubmits biologics license application to FDA
2M ago
OTLK
Outlook Therapeutics Announces Registered Direct Equity Offering
PremiumCompany Announcements
Outlook Therapeutics Announces Registered Direct Equity Offering
2M ago
8K
OTLK
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
NFE
YSS
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
Premium
Company Announcements
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
2M ago
8K
OTLK
Outlook Therapeutics announces pricing of $5M registered direct offering
Premium
The Fly
Outlook Therapeutics announces pricing of $5M registered direct offering
2M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >